AKT1 and ovarian cancer: In the present study, our data demonstrated that the expression of p-Akt and p-mTOR was markedly reduced with dezocine treatment, suggesting that dezocine could suppress activation of the Akt/mTOR signaling pathway in ovarian cancer cells.